Exploring B7-33: A Non-Fibrotic Relaxin Analog in Research
B7-33 is a synthetically engineered relaxin-2 analog designed to preserve beneficial receptor signaling while minimizing pro-fibrotic activity observed with full-length relaxin. By selectively engaging RXFP1-mediated pathways, B7-33 has become a focal point in contemporary research exploring tissue remodeling, vascular biology, and anti-fibrotic signaling without excessive extracellular matrix deposition. Molecular Design and Receptor Selectivity B7-33 is…